Study Title
AOST2031: A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Protocol ID
AOST2031
Disease (Sub Disease)
Metastatic Malignant Neoplasm in the Lung
Metastatic Osteosarcoma
Osteosarcoma
Metastatic Osteosarcoma
Osteosarcoma
Diagnosis Stage
Newly diagnosed
Location
NSW, VIC, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Christchurch Hospital
Starship Children's Hospital
Royal Children's Hospital
Perth Children's Hospital
The Children's Hospital at Westmead
Starship Children's Hospital
Royal Children's Hospital
Perth Children's Hospital
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 50 Years
International registry ID's
NCT05235165
| Study Title | AOST2031: A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma |
|---|---|
| Protocol ID | AOST2031 |
| Disease (Sub Disease) | Metastatic Malignant Neoplasm in the Lung Metastatic Osteosarcoma Osteosarcoma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW / VIC / WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT05235165 |
| Trial Status | Open |
| Trial Open Date | 13/01/2023 |
| Sites | Christchurch Hospital / Starship Children's Hospital/ Royal Children's Hospital / Perth Children's Hospital/ The Children's Hospital at Westmead |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 50 Years |
| International registry ID's | NCT05235165 |